New development of trump healthcare: NIH gets another $2 billion to develop precision medicine
-
Last Update: 2017-05-04
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: healthcare IT news 2017-05-04 on Sunday, representatives passed the health insurance fund spending bill, and the Democratic Party won The bill states that $50 million will be spent to fight opioid abuse But for insurance companies, the move will not help them to gain a foothold in the affordable healthcare bill market As expected, the bill does not mention the payment of cost sharing reduction (CRS) to insurance companies with congressional fund sharing Insurance companies believe that CRS payment at this stage is very necessary to maintain the stability and integrity of market premiums in the Affordable Care Act (ACA) In addition, the Centers for Disease Control and prevention received $7.3 billion, including grants and transfers of ACA prevention and public health funds, while another $42 million expansion sought to combat the abuse of prescription drugs Health resources and Services Administration , HSRA) received $1.5 million in funding, and plans to create an effective telemedicine center in the suburbs to test the effectiveness of telemedicine services; the Centers for Disease Control and prevention received $6 billion, of which $35 million was spent on emergency funding for the Michigan water crisis in Flint City, and another $394 million was spent on Zika virus prevention and response The National Institutes of Health received another $2 billion, a total of $34 billion, the paper said At present, the research focus of NIH is precision medicine The purpose of developing precision medicine is to make medical decision, practice or product model for patients.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.